Researchers explain how our immune system kills abnormal blood cells

April 8, 2014

A team of researchers at the IRCM, led by André Veillette, MD, explains how our immune system kills abnormal blood cells. Their discovery, recently published in the Journal of Experimental Medicine, could eventually lead to new treatment avenues for leukemia, lymphoma and certain types of infectious viral diseases.

"Our team is studying how can eliminate abnormal hematopoietic (blood) cells," explains Dr. Veillette, Director of the Molecular Oncology research unit at the IRCM. "NK (natural killer) cells are crucial to the immune system and play a critical role in protecting us against viruses and ."

In a previous study, the IRCM researchers found the SAP molecule to be an essential component of NK cells' ability to kill abnormal blood cells, which can be found in blood cancers such as and lymphoma, as well as in certain infectious viral diseases like infectious mononucleosis.

"In addition to SAP, a protein called EAT-2 can also be found in NK cells," adds Dr. Veillette. "We knew that EAT-2 cooperates with SAP, and, with this research project, we wanted to better understand why they are both required for the proper functioning of NK cells."

Using a variety of genetic, biochemical and imaging approaches, the researchers successfully defined the molecular and cellular mechanisms by which EAT-2 controls the activation of NK cells.

"We identified the molecular chain of events that occur, and showed that EAT-2 and SAP perform different functions using distinct mechanisms," says Dr. Veillette. "These findings explain the cooperative and essential function of these two molecules in activating NK cells, thereby allowing them to kill abnormal ."

"EAT-2 and SAP are molecules found inside NK , and they are linked to receptors of the SLAM family on the cell surface," concludes Dr. Veillette. "Because they can make better drug targets, our future work will focus on these receptors, which could eventually lead to identifying new potential treatment avenues for blood cancers such as leukemia and lymphoma."

According to the Leukemia & Lymphoma Society of Canada, one person in Canada is diagnosed with a approximately every 28 minutes. In 2013, leukemia, lymphoma, myeloma and myelodysplastic syndromes caused an estimated 6,850 deaths in the country. Leukemia and lymphoma also account for almost half of all childhood cancers (age 0-14 years).

More information: jem.rupress.org/content/early/2014/03/25/jem.20132038.abstract

Related Stories

Cocktail boosts immune cells in fighting cancer

December 6, 2012

Natural killer cells, as part of the body´s immune system, can effectively fight cancer. Unfortunately, they quickly lose their aggressiveness and hence are unable to reject solid tumors. Scientists from the German Cancer ...

Recommended for you

New insight into how the immune system sounds the alarm

August 3, 2015

T cells are the guardians of our bodies: they constantly search for harmful invaders and diseased cells, ready to swarm and kill off any threats. A better understanding of these watchful sentries could allow scientists to ...

How to become a T follicular helper cell

July 30, 2015

Follicular helper Tcells (TFH cells), a rare type of immune cell that is essential for inducing a strong and lasting antibody response to viruses and other microbes, have garnered intense interest in recent years but the ...

Uncovering the secrets of immune system invaders

July 20, 2015

The human immune system is a powerful and wonderful creation. If you cut your skin, your body mobilizes a series of different proteins and cells to heal the cut. If you are infected by a virus or bacteria, your immune system ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.